TissGeneSummary for LCE1C |
Gene summary |
Basic gene information | Gene symbol | LCE1C |
Gene name | late cornified envelope 1C | |
Synonyms | LEP3 | |
Cytomap | UCSC genome browser: 1q21.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001276331.1, NM_178351.3, | |
Description | late cornified envelope protein 1Clate envelope protein 3 | |
Modification date | 20141207 | |
dbXrefs | MIM : 612605 | |
HGNC : HGNC | ||
HPRD : 13967 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_LCE1C | |
BioGPS: 353133 | ||
Pathway | NCI Pathway Interaction Database: LCE1C | |
KEGG: LCE1C | ||
REACTOME: LCE1C | ||
Pathway Commons: LCE1C | ||
Context | iHOP: LCE1C | |
ligand binding site mutation search in PubMed: LCE1C | ||
UCL Cancer Institute: LCE1C | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Skin | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | SKCM | |
Reference showing the relevant tissue of LCE1C | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for LCE1C |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUSC | 0.627789445 | -1.439230163 | 2.067019608 | 2.02E-09 | 6.74E-09 |
Top |
TissGene-miRNA for LCE1C |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for LCE1C |
TissGeneSNV for LCE1C |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.T17I | CESC | 3 |
p.S6N | CESC | 2 |
p.N15I | THCA | 1 |
p.G111S | PRAD | 1 |
p.C22Y | SKCM | 1 |
p.C10* | LUAD | 1 |
p.C33F | LUAD | 1 |
p.R83H | STAD | 1 |
p.S41F | BRCA | 1 |
p.R83H | CESC | 1 |
p.C16Y | COAD | 1 |
p.G108A | PRAD | 1 |
p.P30L | SKCM | 1 |
p.C52Y | SKCM | 1 |
p.S74N | SKCM | 1 |
p.G115E | SKCM | 1 |
p.G66R | SKCM | 1 |
p.R81M | UCEC | 1 |
p.Q91H | COAD | 1 |
p.Q91* | BLCA | 1 |
p.K23M | BRCA | 1 |
p.P25S | STAD | 1 |
p.P18H | LUAD | 1 |
p.H79Q | LUSC | 1 |
p.G49R | OV | 1 |
p.R82H | HNSC | 1 |
p.R83C | PAAD | 1 |
p.G19E | SKCM | 1 |
p.G65V | LUAD | 1 |
p.G65V | HNSC | 1 |
p.G65W | LUAD | 1 |
p.R84T | PRAD | 1 |
p.G66E | LUSC | 1 |
p.K15M | THCA | 1 |
p.S104N | SKCM | 1 |
p.P25S | PAAD | 1 |
p.K28R | STAD | 1 |
p.S100L | STAD | 1 |
p.G49E | SKCM | 1 |
p.R83C | LUAD | 1 |
p.S41Y | LUAD | 1 |
Top |
TissGeneCNV for LCE1C |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for LCE1C |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for LCE1C |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for LCE1C |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for LCE1C |
TissGeneDrug for LCE1C |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for LCE1C |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0028754 | Obesity | 2 | BeFree |
umls:C0003872 | Arthritis, Psoriatic | 1 | GAD |
umls:C0020538 | Hypertensive disease | 1 | BeFree |
umls:C0040336 | Tobacco Use Disorder | 1 | GAD |